Søgeresultater - Jean‐Marie Nicolas

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions

    Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions af Jean‐Marie Nicolas, François Bouzom, Hugues Chanteux, Anna‐Lena Ungell

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    A review of the drug−drug interactions of the antiepileptic drug brivaracetam

    A review of the drug−drug interactions of the antiepileptic drug brivaracetam af Brian D. Moseley, Hugues Chanteux, Jean‐Marie Nicolas, Cédric Laloyaux, Barry E. Gidal, Armel Stockis

    Udgivet 2020
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  3. 3
    Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis

    Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights into Brivaracetam Hydrolysis af Armel Stockis, Shikiko Watanabe, André Scheen, D. Tytgat, Brigitte Gerin, Mónica Rosa, Hugues Chanteux, Jean‐Marie Nicolas

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Brivaracetam: Rationale for discovery and preclinical profile of a selective <scp>SV</scp>2A ligand for epilepsy treatment

    Brivaracetam: Rationale for discovery and preclinical profile of a selective <scp>SV</scp>2A ligand for epilepsy treatment af Henrik Klitgaard, Alain Matagne, Jean‐Marie Nicolas, Michel Gillard, Yves Lamberty, Marc De Ryck, Rafał M. Kamiński, Karine Leclercq, Isabelle Niespodziany, Christian Wolff, Martyn Wood, Jonas Hannestad, Sophie Kervyn, Benoît Kenda

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  5. 5
    Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (<scp>SV</scp>2A) ligand with preclinical evidence of high brain permeability and fast onset of action

    Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (<scp>SV</scp>2A) ligand with preclinical evidence of high brain permeability and fast onset of action af Jean‐Marie Nicolas, Jonas Hannestad, Daniel Holden, Sophie Kervyn, Nabeel Nabulsi, D. Tytgat, Yiyun Huang, Hugues Chanteux, Ludovicus Staelens, Alain Matagne, François‐Xavier Mathy, Joël Mercier, Armel Stockis, Richard E. Carson, Henrik Klitgaard

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Assessment of a white matter reference region for <sup>11</sup>C-UCB-J PET quantification

    Assessment of a white matter reference region for <sup>11</sup>C-UCB-J PET quantification af Samantha Rossano, Takuya Toyonaga, Sjoerd J. Finnema, Mika Naganawa, Yihuan Lu, Nabeel Nabulsi, Jim Ropchan, Steven De Bruyn, Christian Otoul, Armel Stockis, Jean‐Marie Nicolas, Paul Martín, Joël Mercier, Yiyun Huang, R. P. Maguire, Richard E. Carson

    Udgivet 2019
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers

    A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers af Sjoerd J. Finnema, Samantha Rossano, Mika Naganawa, Shannan Henry, Hong Gao, Richard Pracitto, R. P. Maguire, Joël Mercier, Sophie Kervyn, Jean‐Marie Nicolas, Henrik Klitgaard, Steven DeBruyn, Christian Otoul, Paul Martín, Pierandrea Muglia, David Matuskey, Nabeel Nabulsi, Yiyun Huang, Rafal M. Kaminski, Jonas Hannestad, Armel Stockis, Richard E. Carson

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: